Skip to main content
. 2015 Feb 10;112(6):1037–1041. doi: 10.1038/bjc.2015.56

Table 4. Economic analyses of cancer new drugs introduced from 1995 to 2014.

  Average cost per day on treatment (% of daily GDP per capita) Average cost per median duration of treatment (% of annual GDP per capita)
1995–1999 £33.25 (82.6%) £3037 (20.6%)
2000–2004 £49.66 (97.3%) £7973 (43.4%)
2005–2009 £143.70 (233.4%) £20 233 (89.0%)
2010–2014 £160.34 (235.1%) £35 383 (141.7%)

Abbreviation: GDP=gross domestic product.

The average of the median cost of treatment with the new agents introduced in each 5-year period is shown as the contemporary actual cost figure and as a percentage of the UK GDP per capita in the first year of listing in the British National Formulary.